Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Treasury Shares (2021 - 2025)

Rapid Micro Biosystems' Treasury Shares history spans 5 years, with the latest figure at $3.0 million for Q3 2025.

  • For Q3 2025, Treasury Shares rose 41.32% year-over-year to $3.0 million; the TTM value through Sep 2025 reached $3.0 million, up 41.32%, while the annual FY2024 figure was $1.9 million, 15.46% up from the prior year.
  • Treasury Shares for Q3 2025 was $3.0 million at Rapid Micro Biosystems, down from $3.2 million in the prior quarter.
  • Across five years, Treasury Shares topped out at $3.2 million in Q2 2025 and bottomed at $155565.0 in Q3 2022.
  • The 5-year median for Treasury Shares is $1.8 million (2023), against an average of $1.4 million.
  • The largest annual shift saw Treasury Shares plummeted 37.5% in 2022 before it soared 1045.76% in 2023.
  • A 5-year view of Treasury Shares shows it stood at $248903.0 in 2021, then plummeted by 37.5% to $155565.0 in 2022, then soared by 981.07% to $1.7 million in 2023, then grew by 15.46% to $1.9 million in 2024, then skyrocketed by 53.37% to $3.0 million in 2025.
  • Per Business Quant, the three most recent readings for RPID's Treasury Shares are $3.0 million (Q3 2025), $3.2 million (Q2 2025), and $2.6 million (Q1 2025).